Who backs Bluejay Therapeutics?
13 investors| Investor | Type |
|---|---|
| RA Capital Management | Asset manager |
| Novo Holdings | Other |
| Wellington Management | Asset manager |
| T. Rowe Price Group | — |
| Frazier Healthcare Partners | Venture capital |
| Octagon Capital Advisors | Hedge fund |
| Arkin Bio Ventures | — |
| HBM Healthcare Investments | — |
| InnoPinnacle | — |
| RiverVest Venture Partners | — |
| + 3 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Bluejay Therapeutics investors
13 investors are on record for Bluejay Therapeutics, including RA Capital Management, Novo Holdings, Wellington Management and T. Rowe Price Group. The Series C in May 2024 drew 8 investors.
Free account
More of Bluejay Therapeutics with a free account
- ·The complete investor list: 13 names
- ·Watch Bluejay Therapeutics: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 13 firms already write checks for companies like Bluejay Therapeutics in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View